PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 

Foamix Ltd

Press Releases

Click on the press release below to view it in its entirety

Receive press releases from Foamix Ltd: By Email RSS Feeds:
Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, announced today that the Company has obtained another granted patent in Mexico. - June 05, 2012
Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, today announced that the company has been granted a new patent from United States Patent Office. - April 27, 2012
Targets a $1 billion a year market. Foamix, a clinical stage specialty pharmaceutical company, announced today the successful completion of the Phase II clinical trial of Minocycline foam in Impetigo patients. Minocycline Foam has shown to be highly effective against bacteria, including some multi-drug resistant strains (such as MRSA). - March 20, 2012
Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, today announced that the company has been granted a new patent from United States Patent Office. - March 15, 2012
Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, today announced that the company has been granted a new patent from United States Patent Office. - March 13, 2012
Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, today announced that the company has been granted a new patent from United States Patent Office. - March 13, 2012
Foamix Ltd., a clinical-stage specialty pharmaceutical company, that is developing proprietary dermatological and gynecologic topical foam products, today announced that the company has been granted a patent from Indian Patent Office # IN 249626, entitled “Foam Carrier Containing Amphiphilic Copolymeric Gelling Agent.” - February 10, 2012
Most Dermatologists are concerned with Oral Minocycline side effects and will prefer prescribing their patients Topical Minocycline for Rosacea, Acne, Skin Infections and Chronic Wounds. - August 02, 2011
Arkin Holdings and Foamix today announced that they have established a collaboration to develop and commercialize an innovative topical foam to treat patients with acne vulgaris and related disorders. - May 27, 2011
The first-in-class topical Minocycline product, protected by 4 patent applications, is directed for the treatment of Rosacea, Acne, Skin Infections and Chronic Wounds - January 20, 2011
Oleaginous Foams – Ideal Vehicles for Lipophilic and Water-Sensitive Drugs, such as Vitamin D, Retinoids and Lipophilic Antibiotics. - November 06, 2010
The New Drug Will Target One of the Most Common Sexually Transmitted Disease, Afflicting More Than 20 Million Americans. - November 03, 2010
The patent describes unique pharmaceutical foams and their use to deliver a wide range of active agents to treat skin and body cavity conditions. - May 21, 2010
The Patent Covers Foams with Urea, Lactic Acid, Salicylic Acid and Penetration Enhancers - May 01, 2010
Press Releases 1 - 14 of 14 Page: 1
Promote Your Business